The mission of the Melanoma Research Alliance (MRA) is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.
The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) focused on pre-clinical, translational, and early clinical research aiming for high-impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment. The grant emphasizes translational science to bridge the gap between scientific discoveries and the development of clinical trials and studies, targeting melanoma detection, prevention, diagnosis, and treatment. Specific areas of interest include prevention strategies informed by understanding melanomagenesis, the development of innovative detection and diagnostic methods, and the translation of scientific findings into new treatments. Examples of treatment-related research include studies on immunotherapy, molecular mechanisms, the tumor environment, and novel biomarkers. Additionally, the Young Investigator Awards support early-career faculty with funding for innovative research projects in these areas.